how long have glp-1 drugs been on the market Weight Loss Drug Size, Share GLP 1 Investment Thesis -

[DOI] [PubMed] [Google Scholar] 748.Sirohi S., Schurdak J.D., Seeley R.J., Benoit S.C., Davis J.F

But the drug helped

The evidence here is largely preclinical

5 Additionally, clinical trials have shown GLP-1 RAs to have beneficial effects on lipid profiles and blood pressure

Past, Present and Future Perspectives in Nonalcoholic Fatty Liver Disease

Moreover, ALT-801 is a balanced dual receptor agonist 19,20 with closely matched potencies at the GLP-1R and GCGR (39 pM and 42 pM, respectively 20 ), as distinguished from the dual agonists cotadutide 42 and BI456906 43 , which appear to be biased 5:1 and 7.5:1, respectively, toward GLP-1R activation